Hi all, stage IV appendix cancer with signet ring features that have spread to the peritoneum with mucin here. Just...
Understanding Your Situation & Treatment Options
I want to acknowledge that you're dealing with a lot right now—FOLFOXIRI is genuinely one of the more intensive chemotherapy regimens, and it's completely understandable to feel scared about adding another treatment. Let me help you understand what your test results mean and what questions might be helpful to ask your team.
What Your Caris Results Tell You
The good news in your results: Your tumor is KRAS/NRAS wild-type (meaning these genes are NOT mutated). This is actually significant because it opens up a specific treatment pathway.
Here's the clinical reasoning: Doctors use molecular testing to understand what "drives" your cancer—what genetic changes are fueling its growth. For appendix cancers with peritoneal involvement (like yours), KRAS mutations are common, but when they're absent, it suggests your tumor may respond better to EGFR-targeted therapy (which is what panitumumab is).
Panitumumab is a monoclonal antibody—think of it as a targeted missile that blocks a specific growth signal (EGFR) on cancer cells. According to treatment approaches for colorectal and appendix cancers, EGFR inhibitors like panitumumab are typically considered for patients whose tumors lack KRAS/NRAS mutations, which is exactly your situation.
About the Skin Rash Side Effect
The acne-like rash (called acneiform rash) is actually one of the most common side effects of EGFR inhibitors, occurring in 50-80% of patients. Important context: This rash is NOT an allergic reaction—it's a sign the drug is working at the cellular level. Many patients manage it successfully.
Common management strategies include:
- Gentle skin care (mild cleanser, moisturizer, sunscreen SPF 30+)
- Topical treatments (your oncology team may prescribe doxycycline or topical antibiotics)
- Avoiding irritants (harsh soaps, hot water)
- Some patients use makeup to cover it
- Rarely, the rash is severe enough to require dose adjustment
Your Specific Questions to Ask Your Oncology Team
Given that you're about to start this combination on October 6th, here are targeted questions that will help you prepare:
-
"How will you monitor my response to adding panitumumab to my FOLFOXIRI? What imaging or markers will you track?"
- This helps you understand the plan and timeline for assessing whether the combination is working.
-
"What's the expected timeline for the skin rash to appear, and what's your specific protocol for managing it if it develops?"
- Different centers have different approaches—some are more aggressive with preventive treatment.
-
"Given how difficult cycle 5 has been, are there any supportive care adjustments we should consider for cycle 6?"
- FOLFOXIRI is cumulative, and your team may have strategies to help with fatigue, neuropathy, or other side effects.
-
"Are there any lab values or symptoms that would prompt you to pause or adjust the panitumumab specifically?"
- Understanding the safety monitoring helps you know what to report.
-
"Do you have patients on this exact combination I could connect with, or are there support resources specific to EGFR inhibitor side effects?"
- Real-world experience from others on the same regimen can be invaluable.
Important Context About Your Cancer Type
Appendix cancer with peritoneal involvement and signet ring features is complex. The fact that your oncologist is adding panitumumab suggests they're using a personalized approach based on your molecular profile—which is exactly how modern cancer care should work.
The FOLFOXIRI regimen you're on is aggressive because appendix cancers with peritoneal spread require aggressive treatment. Adding panitumumab represents an attempt to enhance that effect by targeting a specific pathway your tumor appears to depend on.
A Note on Your Fear
It's completely valid to feel scared after 5 brutal cycles. Your body has been through a lot. At the same time, the fact that your team is making treatment adjustments based on molecular testing suggests they're actively working to optimize your care. That's a positive sign.
Consider asking your team:
- What does "response" look like at this point? (Are they looking for shrinkage, stability, or something else?)
- What's the plan if you need a treatment break?
- Are there integrative supportive care options (nutrition support, exercise programs, mental health resources) available?
Finding Community & Support
While I can't connect you directly with other patients on this regimen, organizations like the American Cancer Society and Cancer Support Community have support groups specifically for gastrointestinal and appendix cancers. Many have virtual options, which might be easier during active treatment.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
You've made it through 5 cycles of one of the toughest regimens out there. That takes real strength. Your questions and concerns are exactly what you should be bringing to your October 6th appointment.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
- Anyone with stage 4 stomach cancer (signet ring) with spread to the Peritoneum that made it conversion surgery and...
- Hi hi all! I'm looking for a little advice. I have stage 4 appendix cancer with metastasis to the entire peritoneum...
- Appendix cancer that metastasized to the peritoneum. I had CRS/HIPEC last October and had been receiving clear scans...
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 5, 2026. Informational only — not a substitute for your oncology team.
Question asked:
Hi all, stage IV appendix cancer with signet ring features that have spread to the peritoneum with mucin here. Just finished my 5th cycle of FOLFOXIRI, which has been brutal to say the least. Caris tumor molecular testing came back. KRAS/NRAS not mutated. My onc can add panitumumab to chemo with next cycle on Oct 6th. Main additional side effect: skin, including acne-like rash. Is anyone else on this immunotherapy? If so, how are you handling it? Anyone doing my regimen? I'm scared.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for Appendix cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Appendix cancer
- Hi all my names Dan. I was diagnosed with lung cancer last year stage 3. I have completed my chemotherapy and doing...
- Hi lovey people Thank you all so so much for kind comments on my previous posts. So now the next stage of this new...
- Need recommendations for pancreatic cancer stage 4 that has spread to the liver. What treatment options are available
- Hi all this might be a strange question to ask but last year I was diagnosed with stage 4 kidney and left lung...
- Stage 4 metastatic breast cancer which spread to my bones. I have ivermectin, mebendazole, green tea, and turmeric....
- I’m stage 4 with microscopic cancer cells in peritoneum. Doesn’t show up in scans or surgery. Oncologist recommends...
- Hi everyone ❤️ I’m hoping someone here has had a similar experience. I was diagnosed with papillary thyroid cancer...
- Hi, can anyone tell me what helped with exhaustion after radiation treatments? Thank you!! Blessings to you all!! Mia